Financhill
Back

Akari Therapeutics PLC Quote, Financials, Valuation and Earnings

Akari Therapeutics PLC Price Quote

$1.77
+0.07 (+5.99%)
(Updated: May 2, 2024 at 3:24 AM ET)

Akari Therapeutics PLC Key Stats

Buy
51
Akari Therapeutics PLC (AKTX) is a Buy

Day range:
$1.51 - $1.85
52-week range:
$1.08 - $5.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
158.8K
Avg. volume:
24.1K
1-year change:
-54.05%
Market cap:
$13.2M
Revenue:
$0
EPS:
$-2.04

How Much Does Akari Therapeutics PLC Make?

Data Unavailable

Is Akari Therapeutics PLC Growing As A Company?

Data Unavailable

Akari Therapeutics PLC Stock Price Performance

What Is Akari Therapeutics PLC 52-Week High & Low?

Akari Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akari Therapeutics PLC?

Is Akari Therapeutics PLC Cash Flow Positive?

Data Unavailable

Akari Therapeutics PLC Return On Invested Capital

Data Unavailable

Akari Therapeutics PLC Earnings Date & Stock Price

Akari Therapeutics PLC Competitors

Akari Therapeutics PLC Dividend Yield

Data Unavailable

Akari Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 100%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 80.00
Upside from Last Price: 4605.88%

Major Shareholders

  • How many AKTX shares are owned by institutional investors?
    129.4K AKTX shares are owned by institutional investors
  • How many AKTX shares are owned by insiders?
    2.9B AKTX shares are owned by insiders